Retatrutide is a new pharmaceutical in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these https://lawsonkyjn815873.ezblogz.com/67797351/tirzepatide-a-promising-new-treatment-for-obesity